Microneedles Market Expands as Vaccine Patch and Biofertiliser Breakthroughs Accelerate Adoption

Microneedles Market Size to Hit USD 2.38 Billion by 2030 as Dual-Use Breakthroughs in Vaccine Delivery and Biofertiliser Systems Accelerate Adoption

A series of 2025–2026 scientific breakthroughs across agricultural biotechnology and veterinary immunisation has intensified global momentum in microneedle technologies, reinforcing their transition from experimental drug delivery systems to scalable cross-sector platforms. The global Microneedles Market, valued at USD 1.65 billion in 2024, is projected to reach USD 2.38 billion by 2030, expanding at a CAGR of 6.3% during 2025–2030, driven by rising demand for minimally invasive delivery systems in both healthcare and agriculture.

Recent institutional research from the National University of Singapore (NUS) demonstrated a dissolvable microneedle patch capable of delivering biofertiliser directly into plant tissue, significantly improving growth efficiency while reducing biofertiliser use by over 15%. In parallel, University of Connecticut researchers, in collaboration with the U.S. Department of Agriculture, developed a temperature-stable microneedle patch vaccine for foot-and-mouth disease, eliminating the need for traditional injections and cold-chain logistics. 

Cross-Sector Breakthroughs Redefining Market Expansion

The microneedles sector is witnessing a structural shift from single-use pharmaceutical applications to dual-sector deployment spanning healthcare and agriculture. The convergence of these two domains is expanding the addressable market beyond conventional dermatological and vaccine delivery systems.

Sikha Haritwal, Senior Research Analyst at Next Move Strategy Consulting, notes that recent developments indicate a clear transition toward platform-based delivery technologies. “Microneedle systems are no longer confined to transdermal therapeutics. Their adaptation for agricultural bio-delivery and livestock immunisation marks a fundamental expansion of their commercial scope,” she stated.

According to the latest NMSC proprietary dataset, dual-use innovation cycles in 2025–2026 have accelerated pilot-scale deployments, particularly in controlled agriculture environments and veterinary immunisation programs where precision dosing and reduced waste are critical.

Key 2025–2026 Scientific Developments

1. Agricultural Biofertiliser Microneedle System (NUS)

Researchers at NUS developed dissolvable polyvinyl alcohol (PVA)-based microneedle patches infused with beneficial microbes, enabling direct delivery into plant tissue. This bypasses soil-based inefficiencies such as microbial competition and nutrient loss. The system demonstrated:

• Over 15% reduction in biofertiliser usage 

• Improved plant growth in Choy Sum and Kale 

• Enhanced nutrient absorption efficiency 

• Stable microbial viability for up to four weeks 

The study was published in Advanced Functional Materials (2025), marking a significant step toward precision agriculture applications.

2. Livestock Vaccine Microneedle Patch (UConn + USDA)

University of Connecticut researchers developed a sucrose-stabilized adenovirus vaccine patch for foot-and-mouth disease, eliminating the need for injections and cold-chain storage. Key findings include:

• Room-temperature stability for weeks 

• Heat resistance up to 45°C for one month 

• Equivalent antibody response compared to injectable vaccines 

• Reduced animal stress and meat quality degradation 

The innovation addresses one of the most economically severe livestock diseases, with potential outbreak damages estimated at up to USD 228 billion in the U.S. alone.

Market Impact Analysis (2025–2030 Shift Dynamics)

The integration of microneedle technology into agriculture and veterinary medicine is reshaping traditional demand structures. Previously concentrated in dermatology and vaccine delivery, the market is now expanding into precision agriculture and livestock health management.

Market Size Overview

Regional Growth Trends

Application Segmentation

Strategic Implications for Industry Stakeholders

Pharmaceutical Companies: Expand investment in temperature-stable microneedle vaccine platforms 

Agri-biotech Firms: Integrate microbial delivery systems into controlled-environment farming 

Livestock Health Providers: Transition toward needle-free immunisation technologies 

Manufacturing Firms: Scale microfabrication capabilities for biodegradable patch production 

Investors: Prioritize dual-use microneedle platforms with cross-sector scalability 

Conclusion

The microneedles market is entering a new phase of structural expansion driven by convergence across healthcare, agriculture, and veterinary applications. With validated breakthroughs in both plant biofertilisation and livestock vaccine delivery, the technology is evolving into a multi-industry platform with sustained growth potential through 2030.

About Next Move Strategy Consulting:

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes NMSC different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more information, please contact:

Next Move Strategy Consulting

5th Floor 867

Boylston St, STE 500,

Boston, MA 02116, U.S.

E-Mail: [email protected] 

Direct: +1-217-650-7991

Website: www.nextmsc.com